Quick Answer
TANDEM DIABETES CARE INC reported Cash And Cash Equivalents At Carrying Value of $90.63 million for the year ending 2025.
- TANDEM DIABETES CARE INC showed an increase of +30.9% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from TANDEM DIABETES CARE INC's annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: $29.44 million | Q2 2013: $30.13 million | Q3 2013: $15.55 million | Q1 2014: $76.83 million | Q2 2014: $64.21 million | Q3 2014: $35.56 million | Q1 2015: $62.55 million | Q2 2015: $45.92 million | Q3 2015: $43.21 million | Q1 2016: $40.61 million | Q2 2016: $30.25 million | Q3 2016: $17.96 million | Q1 2017: $40.33 million | Q2 2017: $27.35 million | Q3 2017: $12.08 million | Q1 2018: $62.58 million | Q2 2018: $50.55 million | Q3 2018: $32.33 million | Q1 2019: $40.45 million | Q2 2019: $38.16 million | Q3 2019: $46.06 million | Q1 2020: $74.49 million | Q2 2020: $222.48 million | Q3 2020: $129.48 million | Q1 2021: $120.79 million | Q2 2021: $98.58 million | Q3 2021: $112.38 million | Q1 2022: $93.68 million | Q2 2022: $114.97 million | Q3 2022: $123.79 million | Q1 2023: $127.76 million | Q2 2023: $130.75 million | Q3 2023: $79.61 million | Q1 2024: $58.98 million | Q2 2024: $47.70 million | Q3 2024: $49.04 million | Q1 2025: $53.57 million | Q2 2025: $64.11 million | Q3 2025: $91.95 million.
- Over the full 15 years of available data (2011 to 2025), TANDEM DIABETES CARE INC's Cash And Cash Equivalents At Carrying Value has grown by 946.9%.
- Historical annual values: Fiscal year 2025: $90.63 million | Fiscal year 2024: $69.23 million | Fiscal year 2023: $58.87 million | Fiscal year 2022: $172.52 million | Fiscal year 2021: $71.18 million | Fiscal year 2020: $94.61 million | Fiscal year 2019: $51.18 million | Fiscal year 2018: $41.83 million | Fiscal year 2017: $13.70 million | Fiscal year 2016: $44.68 million | Fiscal year 2015: $43.09 million | Fiscal year 2014: $31.18 million | Fiscal year 2013: $124.39 million | Fiscal year 2012: $17.16 million | Fiscal year 2011: $8.66 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: